Novo Nordisk A/S (NONOF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:25PM EDT
| Previous close | 123.50 |
| Open | 129.08 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 123.30 - 130.00 |
| 52-week range | 74.70 - 140.32 |
| Volume | |
| Avg. volume | 42,548 |
| Market cap | 559.833B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 46.68 |
| EPS (TTM) | 2.67 |
| Earnings date | N/A |
| Forward dividend & yield | 1.86 (1.51%) |
| Ex-dividend date | 22 Mar 2024 |
| 1y target est | N/A |
Investor's Business DailyDow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.
Yahoo Finance UKStocks to watch next week: Amazon, Apple, Anglo American and Novo Nordisk
Earnings preview of key companies reporting next week and what to look out for.
Globe NewswireNovo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred. Referring to Company Announcement no 32/2024 dated 24 April 2024, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 26 April 2024. Number of
© 2024 Yahoo. All rights reserved.